VECT Key Statistics, Chart & Performance
The current stock price of VECT is 16.85 USD. In the past month the price increased by 1.08%. In the past year, price increased by 186.54%.
VECT Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to VECT. When comparing the yearly performance of all stocks, VECT is one of the better performing stocks in the market, outperforming 98.97% of all stocks.
VECT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to VECT. The financial health of VECT is average, but there are quite some concerns on its profitability.
VECT Financial Highlights
Over the last trailing twelve months VECT reported a non-GAAP Earnings per Share(EPS) of -1.87. The EPS increased by 22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.05 |
VECT Forecast & Estimates
8 analysts have analysed VECT and the average price target is 18.36 USD. This implies a price increase of 8.96% is expected in the next year compared to the current price of 16.85.
For the next year, analysts expect an EPS growth of 8.67% and a revenue growth -96.99% for VECT
VECT Ownership
VECT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.08 | 387.092B | ||
| AMGN | AMGEN INC | 16.32 | 198.053B | ||
| GILD | GILEAD SCIENCES INC | 16.72 | 185.32B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.54 | 116.409B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.5 | 80.573B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 46.25 | 43.76B | ||
| INSM | INSMED INC | N/A | 32.21B | ||
| NTRA | NATERA INC | N/A | 27.199B | ||
| BIIB | BIOGEN INC | 12 | 27.192B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.25 | 20.623B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About VECT
Company Profile
VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. The company is headquartered in Basel, Basel-Stadt and currently employs 42 full-time employees. The company went IPO on 2021-04-09. The firm trough it's subsidiaries operates as a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of treatments for severe rare conditions for which there is a significant unmet medical need.
Company Info
VectivBio Holding AG
Aeschenvorstadt 36
Basel BASEL-STADT 22046 CH
Employees: 42
Phone: 41615513030.0
VectivBio Holding AG / VECT FAQ
Can you describe the business of VectivBio Holding AG?
VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. The company is headquartered in Basel, Basel-Stadt and currently employs 42 full-time employees. The company went IPO on 2021-04-09. The firm trough it's subsidiaries operates as a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of treatments for severe rare conditions for which there is a significant unmet medical need.
What is the current price of VECT stock?
The current stock price of VECT is 16.85 USD.
Does VECT stock pay dividends?
VECT does not pay a dividend.
What is the ChartMill technical and fundamental rating of VECT stock?
VECT has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the market expecting VECT stock to perform?
8 analysts have analysed VECT and the average price target is 18.36 USD. This implies a price increase of 8.96% is expected in the next year compared to the current price of 16.85.
Can you provide the PE ratio for VECT stock?
VectivBio Holding AG (VECT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.87).
What is the market capitalization of VECT stock?
VectivBio Holding AG (VECT) has a market capitalization of 1.06B USD. This makes VECT a Small Cap stock.